Alcon's AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens Approved By FDA

Fort Worth, TX - Alcon Laboratories, Inc., a subsidiary of Alcon, Inc., announced recently that the U.S. Food and Drug Administration (FDA) has granted approval of the AcrySof ReSTOR apodized diffractive aspheric intraocular lens for the visual correction of aphakia following cataract surgery in adult patients with and without presbyopia. The AcrySof ReSTOR apodized diffractive aspheric intraocular lens is the only FDA-approved presbyopia-correcting intraocular lens that incorporates aspheric optics into its design. Alcon will begin a phased commercial launch of this new lens after necessary consignment quantities are established, with full distribution expected by the middle of the year.

For more information on Alcon, Inc., you can visit www.alcon.com.

SOURCE: Alcon